Skip to main content
Top
Published in: Abdominal Radiology 1/2008

01-01-2008

PET–CT vs. CT alone in ovarian cancer recurrence

Authors: Sunit Sebastian, Susanna I. Lee, Neil S. Horowitz, James A. Scott, Alan J. Fischman, Joseph F. Simeone, Arlan F. Fuller, Peter F. Hahn

Published in: Abdominal Radiology | Issue 1/2008

Login to get access

Abstract

Background

To compare fusion, positron emission tomography–computed tomography (PET–CT) with CT alone in detecting ovarian carcinoma recurrence.

Methods

Fifty-one consecutive patients underwent 53 restaging PET–CT scans with a concurrent diagnostic quality CT scan. Two body imaging radiologists independently assessed the CT’s; each then teamed with a nuclear medicine specialist to review the PET–CT’s. Two teams conferred for consensus on the presence of disease in the chest, abdomen, and body overall with CT alone and with PET–CT, using a six-point reader confidence metric to determine accuracy and receiver operating characteristic (ROC) curves. Reader agreement was compared using kappa. Recurrence was determined by two gynecologic oncologists reviewing clinical records from time of presentation to at least 13 months (mean 22.7) after imaging.

Results

Recurrence was based on histopathology in 17% (9/53). Seventy-two percent (38/53) cases had recurrence, with two cases showing isolated chest recurrence. PET–CT accuracy exceeded CT for body 92% (49/53) vs. 83% (44/53), chest 96% (51/53) vs. 89% (47/53), and abdomen 91% (48/53) vs. 79% (42/53). ROC curves for PET–CT dominated that for CT alone; this difference was statistically significant for abdomen and for body overall (P < 0.01). Interobserver agreement was better for PET–CT than for CT alone.

Conclusions

PET–CT demonstrates greater accuracy and less interobserver variability than CT alone.
Literature
2.
go back to reference Silverberg E, Boring CC, Squires TS (1990) Cancer statistics, 1990. CA Cancer J Clin 40:318–9 Silverberg E, Boring CC, Squires TS (1990) Cancer statistics, 1990. CA Cancer J Clin 40:318–9
3.
4.
go back to reference Nanni C, Rubello D, Farsad M, et al. (2005) (18) F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. Eur J Surg Oncol 31:792–7PubMedCrossRef Nanni C, Rubello D, Farsad M, et al. (2005) (18) F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. Eur J Surg Oncol 31:792–7PubMedCrossRef
5.
go back to reference Look M, Chang D, Sugarbaker PH (2004) Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 14:35–41PubMedCrossRef Look M, Chang D, Sugarbaker PH (2004) Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 14:35–41PubMedCrossRef
6.
go back to reference Niloff JM, Bast RC Jr, Schaetzl EM, et al. (1985) Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 151:981–6PubMed Niloff JM, Bast RC Jr, Schaetzl EM, et al. (1985) Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 151:981–6PubMed
7.
go back to reference Cho SM, Ha HK, Byun JY, et al. (2002) Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol 179:391–5PubMed Cho SM, Ha HK, Byun JY, et al. (2002) Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol 179:391–5PubMed
8.
go back to reference Makhija S, Howden N, Edwards R, et al. (2002) Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85:53–8PubMedCrossRef Makhija S, Howden N, Edwards R, et al. (2002) Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85:53–8PubMedCrossRef
9.
go back to reference Beyer T, Townsend DW, Brun T, et al. (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–79PubMed Beyer T, Townsend DW, Brun T, et al. (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–79PubMed
10.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–74PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–74PubMedCrossRef
11.
go back to reference Zanon C, Clara R, Chiappino I, et al. (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 28:1040–5PubMedCrossRef Zanon C, Clara R, Chiappino I, et al. (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 28:1040–5PubMedCrossRef
12.
go back to reference Rubin SC, Randall TC, Armstrong KA, et al. (1999) Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol 93:21–4PubMedCrossRef Rubin SC, Randall TC, Armstrong KA, et al. (1999) Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol 93:21–4PubMedCrossRef
13.
go back to reference Skates SJ, Xu FJ, Yu YH, et al. (1995) Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 76:2004–10PubMedCrossRef Skates SJ, Xu FJ, Yu YH, et al. (1995) Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 76:2004–10PubMedCrossRef
14.
go back to reference Hogberg T, Kagedal B (1992) Long-term follow-up of ovarian cancer with monthly determinations of serum CA125. Gynecol Oncol 46:191–8PubMedCrossRef Hogberg T, Kagedal B (1992) Long-term follow-up of ovarian cancer with monthly determinations of serum CA125. Gynecol Oncol 46:191–8PubMedCrossRef
15.
go back to reference Ferrozzi F, Bova D, De Chiara F, et al. (1998) Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history. Clin Imaging 22:364–70PubMedCrossRef Ferrozzi F, Bova D, De Chiara F, et al. (1998) Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history. Clin Imaging 22:364–70PubMedCrossRef
16.
go back to reference Funt SA, Hricak H, Abu-Rustum N, et al. (2004) Role of CT in the management of recurrent ovarian cancer. AJR Am J Roentgenol 182:393–8PubMed Funt SA, Hricak H, Abu-Rustum N, et al. (2004) Role of CT in the management of recurrent ovarian cancer. AJR Am J Roentgenol 182:393–8PubMed
17.
go back to reference Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–9PubMedCrossRef Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–9PubMedCrossRef
18.
go back to reference Gryspeerdt S, Clabout L, Van Hoe L, et al. (1998) Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer. Eur J Gynaecol Oncol 19:434–7PubMed Gryspeerdt S, Clabout L, Van Hoe L, et al. (1998) Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer. Eur J Gynaecol Oncol 19:434–7PubMed
19.
go back to reference Rubin SC, Lewis JL Jr (1988) Second-look surgery in ovarian carcinoma. Crit Rev Oncol Hematol 8:75–91PubMedCrossRef Rubin SC, Lewis JL Jr (1988) Second-look surgery in ovarian carcinoma. Crit Rev Oncol Hematol 8:75–91PubMedCrossRef
20.
go back to reference Markus JB, Somers S, O’Malley BP, et al. (1990) Double-contrast barium enema studies: effect of multiple reading on perception error. Radiology 175:155–6PubMed Markus JB, Somers S, O’Malley BP, et al. (1990) Double-contrast barium enema studies: effect of multiple reading on perception error. Radiology 175:155–6PubMed
21.
go back to reference Fultz PJ, Jacobs CV, Hall WJ, Gottlieb R, et al. (1999) Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans. Radiology 212:401–10PubMed Fultz PJ, Jacobs CV, Hall WJ, Gottlieb R, et al. (1999) Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans. Radiology 212:401–10PubMed
22.
go back to reference Sella T, Rosenbaum E, Edelmann DZ, et al. (2001) Value of chest CT scans in routine ovarian carcinoma follow-up. AJR Am J Roentgenol 177:857–9PubMed Sella T, Rosenbaum E, Edelmann DZ, et al. (2001) Value of chest CT scans in routine ovarian carcinoma follow-up. AJR Am J Roentgenol 177:857–9PubMed
23.
go back to reference Sironi S, Messa C, Mangili G, et al. (2004) Integrated FDG PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings. Radiology 233:433–40PubMedCrossRef Sironi S, Messa C, Mangili G, et al. (2004) Integrated FDG PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings. Radiology 233:433–40PubMedCrossRef
24.
go back to reference Picchio M, Sironi S, Messa C, et al. (2003) Advanced ovarian carcinoma: usefulness of 18F-FDG-PET in combination with CT for lesion detection after primary treatment. Q J Nucl Med 47:77–84PubMed Picchio M, Sironi S, Messa C, et al. (2003) Advanced ovarian carcinoma: usefulness of 18F-FDG-PET in combination with CT for lesion detection after primary treatment. Q J Nucl Med 47:77–84PubMed
Metadata
Title
PET–CT vs. CT alone in ovarian cancer recurrence
Authors
Sunit Sebastian
Susanna I. Lee
Neil S. Horowitz
James A. Scott
Alan J. Fischman
Joseph F. Simeone
Arlan F. Fuller
Peter F. Hahn
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9218-0

Other articles of this Issue 1/2008

Abdominal Radiology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.